Unfortunately, ExactMeds™ is not available if you:
RxGenomix’s pharmacogenomic reports include genetic health risk information that has not been reviewed by the FDA. The ExactMedsTM pharmacogenomic service leverages advanced genotype data to identify clinically relevant variants via patient saliva DNA for the purpose of understanding one’s health risk via medication utilization. The ExactMedsTM program is not intended to diagnose any disease. A patient’s ethnicity may affect the relevance of each report and how one’s genetic health risk results are interpreted. Information delivered via the ExactMedsTM service is not intended for a patient to independently act upon a medical decision, but rather to inform and provide the genetic risk information to share directly with their licensed provider. The ExactMedsTM pharmacogenomic reports are not intended to tell a patient anything about their risk for developing a disease in the future.
The ExactMedsTM pharmacogenomic service utilizes genotyping data to identify medication risk factors for the purpose of reporting and interpreting to inform discussions with a healthcare professional. The ExactMedsTM pharmacogenomic report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of those medications.
Warning: Pharmacogenomic test results should not be used to start, stop, or change any course of treatment without consulting with a patient’s provider. The ExactMedsTM pharmacogenomic service is not a substitute for an appointment with a patient’s healthcare professional. For important information and limitations regarding pharmacogenomic testing, please visit: How Pharmacogenomics (PGx) Works – RxGenomix